title: Authors' reply.
authors.affiliation: Andrew F. Leuchter, Semel Institute for Neuroscience and Human Behavior at UCLA, Director of Neuromodulation Division, Los Angeles, USA. Email: afl@ucla.edu; Aimee M. Hunter, Molly Tartter, Ian A. Cook, UCLA, Los Angeles, USA.
authors.forename: Andrew F
authors.initials: AF
authors.lastname: Leuchter
authors.affiliation: Andrew F. Leuchter, Semel Institute for Neuroscience and Human Behavior at UCLA, Director of Neuromodulation Division, Los Angeles, USA. Email: afl@ucla.edu; Aimee M. Hunter, Molly Tartter, Ian A. Cook, UCLA, Los Angeles, USA.
authors.forename: Aimee M
authors.initials: AM
authors.lastname: Hunter
authors.affiliation: Andrew F. Leuchter, Semel Institute for Neuroscience and Human Behavior at UCLA, Director of Neuromodulation Division, Los Angeles, USA. Email: afl@ucla.edu; Aimee M. Hunter, Molly Tartter, Ian A. Cook, UCLA, Los Angeles, USA.
authors.forename: Molly
authors.initials: M
authors.lastname: Tartter
authors.affiliation: Andrew F. Leuchter, Semel Institute for Neuroscience and Human Behavior at UCLA, Director of Neuromodulation Division, Los Angeles, USA. Email: afl@ucla.edu; Aimee M. Hunter, Molly Tartter, Ian A. Cook, UCLA, Los Angeles, USA.
authors.forename: Ian A
authors.initials: IA
authors.lastname: Cook
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D003865:Major Depressive Disorder; D005260:Female; D006801:Humans; D008297:Male; D015990:Placebo Effect; D011613:Psychotherapy / Q000379:methods*
chemical_list: D000928:Antidepressive Agents